Bio-inspired synthesis of PEGylated polypyrrole@polydopamine nanocomposites as theranostic agents for T1-weighted MR imaging guided photothermal therapy

2017 ◽  
Vol 5 (5) ◽  
pp. 1108-1116 ◽  
Author(s):  
Zhe Yang ◽  
Jinghua Ren ◽  
Zhilan Ye ◽  
Wei Zhu ◽  
Liji Xiao ◽  
...  

Polypyrrole nanoparticle (PPy) based theranostic agents for magnetic resonance imaging (MRI) guided photothermal therapy (PTT) have received increasing attention in recent years.

Nanoscale ◽  
2021 ◽  
Author(s):  
Yan Wu ◽  
Yu Huang ◽  
Chunlai Tu ◽  
Fengren Wu ◽  
Gangsheng Tong ◽  
...  

Theranostic agents based on magnetic resonance imaging (MRI) and photothermal therapy (PTT) play an important role in tumor therapy. However, available theranostic agents are confronting great challenges in the issues...


2018 ◽  
Vol 6 (40) ◽  
pp. 6391-6398 ◽  
Author(s):  
Yiming Yu ◽  
Bin Chi ◽  
Leping Lin ◽  
Zhe Yang ◽  
Qianyuan He ◽  
...  

Magnetic resonance imaging (MRI)-guided photothermal therapy (PTT) has recently attracted tremendous attention.


RSC Advances ◽  
2021 ◽  
Vol 11 (12) ◽  
pp. 6472-6476
Author(s):  
Yechao Du ◽  
Daguang Wang ◽  
Shuo Wang ◽  
Wei Li ◽  
Jian Suo

A new nanotheraontic agent for magnetic resonance imaging (MRI) guided combined photothermal therapy (PTT) and chemotherapy has been reported.


2013 ◽  
Vol 20 (1) ◽  
pp. 3-11 ◽  
Author(s):  
Nabeela Nathoo ◽  
V Wee Yong ◽  
Jeff F Dunn

Major advances are taking place in the development of therapeutics for multiple sclerosis (MS), with a move past traditional immunomodulatory/immunosuppressive therapies toward medications aimed at promoting remyelination or neuroprotection. With an increase in diversity of MS therapies comes the need to assess the effectiveness of such therapies. Magnetic resonance imaging (MRI) is one of the main tools used to evaluate the effectiveness of MS therapeutics in clinical trials. As all new therapeutics for MS are tested in animal models first, it is logical that MRI be incorporated into preclinical studies assessing therapeutics. Here, we review key papers showing how MR imaging has been combined with a range of animal models to evaluate potential therapeutics for MS. We also advise on how to maximize the potential for incorporating MRI into preclinical studies evaluating possible therapeutics for MS, which should improve the likelihood of discovering new medications for the condition.


2016 ◽  
Vol 7 (11) ◽  
pp. 6695-6700 ◽  
Author(s):  
Xing Ding ◽  
Jianhua Liu ◽  
Junqi Li ◽  
Fan Wang ◽  
Yinghui Wang ◽  
...  

A multifunctional core/shell nanotheranostic platform was constructed which could offer MRI guided combinational chemotherapy and photothermal therapy for cancer.


2014 ◽  
Vol 2014 ◽  
pp. 1-9 ◽  
Author(s):  
Joyce G. R. Bomers ◽  
Jelle O. Barentsz

The purpose of this paper is to introduce and describe the Prostate Imaging and Reporting Archiving Data System (PI-RADS). For every single parameter the PI-RADS scoring system will be explained and magnetic resonance imaging (MRI) examples will be given. In the end two patient cases are presented to explain the overall interpretation score in multiparametric imaging.


Sign in / Sign up

Export Citation Format

Share Document